ARCHIVES

John Durant Is Chosen “Cancer Fighter of the Year”.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

February 20, 2004

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

NCI Cooperative Group Clinical Trials Approved

April 30, 2010